UA109144C2 - Дезинфицирующий и антисептический препарат с пониженным содержанием йода - Google Patents

Дезинфицирующий и антисептический препарат с пониженным содержанием йода

Info

Publication number
UA109144C2
UA109144C2 UAA201301371A UAA201301371A UA109144C2 UA 109144 C2 UA109144 C2 UA 109144C2 UA A201301371 A UAA201301371 A UA A201301371A UA A201301371 A UAA201301371 A UA A201301371A UA 109144 C2 UA109144 C2 UA 109144C2
Authority
UA
Ukraine
Prior art keywords
disinfectant
lowered
antiseptic agent
iodine content
antiseptic
Prior art date
Application number
UAA201301371A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Ендре Мікуласік
Тамас Спайц
Original Assignee
Егіш Дьодьсердьяр Нільваношан Мюкеде Ресвеньтаршашаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Егіш Дьодьсердьяр Нільваношан Мюкеде Ресвеньтаршашаг filed Critical Егіш Дьодьсердьяр Нільваношан Мюкеде Ресвеньтаршашаг
Publication of UA109144C2 publication Critical patent/UA109144C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12—Iodine, e.g. iodophors; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cleaning By Liquid Or Steam (AREA)
UAA201301371A 2010-07-12 2011-07-12 Дезинфицирующий и антисептический препарат с пониженным содержанием йода UA109144C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1000362A HUP1000362A2 (en) 2010-07-12 2010-07-12 Antiseptic and disinfecting compositions having reduced iodine content
PCT/HU2011/000065 WO2012007776A2 (fr) 2010-07-12 2011-07-12 Formulation désinfectante et antiseptique à teneur réduite en iode

Publications (1)

Publication Number Publication Date
UA109144C2 true UA109144C2 (ru) 2015-07-27

Family

ID=89989820

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201301371A UA109144C2 (ru) 2010-07-12 2011-07-12 Дезинфицирующий и антисептический препарат с пониженным содержанием йода

Country Status (11)

Country Link
EP (1) EP2592935A2 (fr)
AR (1) AR082155A1 (fr)
BR (1) BR112013000690A2 (fr)
EA (1) EA022847B1 (fr)
GE (1) GEP20156236B (fr)
HK (1) HK1150373A2 (fr)
HU (1) HUP1000362A2 (fr)
TW (1) TW201216859A (fr)
UA (1) UA109144C2 (fr)
UY (1) UY33502A (fr)
WO (1) WO2012007776A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012150891A1 (fr) * 2011-05-02 2012-11-08 Lipidor Ab Composition destinée à l'administration d'un agent pharmacologiquement ou cosmétiquement actif sur une surface d'un organisme vivant
GB2521997A (en) 2013-09-06 2015-07-15 Biocompatibles Uk Ltd Radiopaque polymers
WO2016175728A1 (fr) * 2015-04-27 2016-11-03 Aydin Kimya Sanayi Ve Ticaret Anonim Sirketi Procédé de production d'une solution antimicrobienne à base de pdms-i
WO2016209966A1 (fr) 2015-06-22 2016-12-29 Infection Containment Company, LLC Système antiseptique topique
CN110403923B (zh) 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
CA3058097C (fr) 2017-04-21 2024-01-02 Novaliq Gmbh Compositions d'iode
MX2020003534A (es) 2017-09-27 2020-07-29 Novaliq Gmbh Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
CA3111870C (fr) 2018-09-27 2022-04-12 Novaliq Gmbh Formulation d'ecran solaire topique
EP3856124A1 (fr) 2018-09-27 2021-08-04 Novaliq GmbH Réparation de la barrière lipidique
CN112755050B (zh) * 2020-12-31 2022-11-15 佛山市正典生物技术有限公司 一种具有高组分稳定性的不含醇含碘消毒剂及其制备方法
CN114208818B (zh) * 2021-11-09 2022-10-04 佛山市正典生物技术有限公司 包含多元醇醚和/或环醚的含碘消毒剂及制备方法
EP4444371A4 (fr) * 2021-12-09 2025-12-03 I2Pure Corp Polymères à infusion d'iode moléculaire, articles, produits et leur préparation et utilisation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081232A (en) * 1960-12-27 1963-03-12 Warner Lambert Pharmaceutical Iodine preparation and method of disinfecting the skin
US4384960A (en) 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
FR2611734B1 (fr) 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polycondensation contenant de l'iode pour le traitement des eaux
FR2611735B1 (fr) 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
FR2611733B1 (fr) 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2634772A1 (fr) 1988-07-29 1990-02-02 Rhone Poulenc Chimie Composition a base d'huile diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2648143B1 (fr) 1989-06-08 1991-09-06 Rhone Poulenc Chimie Composition comprenant un copolymere silicone thermoplastique et un compose de l'iode, utilisable apres sa mise en forme, pour le traitement des eaux
US6024968A (en) * 1991-08-16 2000-02-15 Lincoln Technologies Inc. Intersorption composition and method
DE19837850C1 (de) 1998-08-20 2000-01-05 Wacker Chemie Gmbh Mischungen flüchtiger linearer Siloxane, Verfahren zu ihrer Herstellung sowie diese enthaltenden kosmetischen Formulierungen
JP2006083119A (ja) * 2004-09-17 2006-03-30 Mandom Corp 殺菌消毒剤組成物
WO2006138035A1 (fr) * 2005-06-13 2006-12-28 Dow Corning Corporation Vehicule pour l'administration d'agents pharmaceutiques solubles lipidiques topiques
CA2618993A1 (fr) * 2005-08-13 2007-02-22 Collegium Pharmaceutical, Inc. Administration topique a l'aide d'un fluide porteur

Also Published As

Publication number Publication date
WO2012007776A3 (fr) 2012-06-07
GEP20156236B (en) 2015-01-26
HK1150373A2 (en) 2011-12-16
TW201216859A (en) 2012-05-01
EA201390090A1 (ru) 2013-05-30
WO2012007776A2 (fr) 2012-01-19
HU1000362D0 (en) 2010-10-28
EP2592935A2 (fr) 2013-05-22
BR112013000690A2 (pt) 2016-05-17
HUP1000362A2 (en) 2012-11-28
AR082155A1 (es) 2012-11-14
EA022847B1 (ru) 2016-03-31
UY33502A (es) 2012-01-31

Similar Documents

Publication Publication Date Title
UA109144C2 (ru) Дезинфицирующий и антисептический препарат с пониженным содержанием йода
IN2014DN06200A (fr)
PH12013500467A1 (en) Pharmaceutical composition
PH12012502460A1 (en) Thioacetate compounds, compositions and methods of use
NZ603151A (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
IN2012DN00692A (fr)
MX2012001618A (es) Derivados de 5-fluoropirimidinona.
PH12013500441A1 (en) Materials and methods for improving gastrointestinal function
UA107445C2 (uk) 5-фторпіримідинові похідні як фунгіциди
IN2015DN00544A (fr)
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX337549B (es) Derivados de insulina que contienen enlaces disulfuro adicionales.
MX2012001620A (es) Derivados de n1-acil-5-fluoropirimidinona.
MX342947B (es) Tratamiento de diabetes tipo 2.
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
IN2012DN01913A (fr)
MX355668B (es) Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes.
MX2011013324A (es) Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor.
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
MX2013005699A (es) Composiciones de interferon-beta estables conservadas.
MX2012007158A (es) Derivados de peroxidos de dibenzoilo, metodo de preparacion de los mismos, composiciones cosmeticas o dermatologicas que los contienen.
TN2012000381A1 (en) 2-aldoximino-5-fluoropyrimidine derivatives
MX2012012324A (es) Formulaciones y usos del derivado del acido 2 - hidroxi -5 - fenilazobenzoico para el tratamiento de varones.
MX2015004310A (es) Formulacion de aroma y fragancia (v).